HealthQuill Oral drugs
Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat specific forms of brain cancer.
Drugs Health Pharma

France’s Servier gets FDA green light for oral drug to treat brain cancer

Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat.

Read More
The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no longer automatically substitutable at the pharmacy due to increased toxicity.
Drugs Health Pharma

FDA rules Accord’s tacrolimus oral drug not “substitutable” for US market

HQ Team September 19, 2023: The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no.

Read More
X